Display options
Cite
Gaude GS, Chaudhury A, Hattiholi J. Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J Family Med Prim Care. 2015;4(2):238-43doi: 10.4103/2249-4863.154661.
Gaude, G. S., Chaudhury, A., & Hattiholi, J. (2015). Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. Journal of family medicine and primary care, 4(2), 238-43. https://doi.org/10.4103/2249-4863.154661
Gaude, Gajanan S, et al. "Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients." Journal of family medicine and primary care vol. 4,2 (2015): 238-43. doi: https://doi.org/10.4103/2249-4863.154661
Gaude GS, Chaudhury A, Hattiholi J. Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J Family Med Prim Care. 2015 Apr-Jun;4(2):238-43. doi: 10.4103/2249-4863.154661. PMID: 25949974; PMCID: PMC4408708.
Copy Download .nbib Format: NLM
Share it on

J Family Med Prim Care. 2015 Apr-Jun;4(2):238-43. doi: 10.4103/2249-4863.154661.

Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients.

Journal of family medicine and primary care

Gajanan S Gaude, Alisha Chaudhury, Jyothi Hattiholi

Affiliations

  1. Department of Pulmonary Medicine, KLE University's J. N. Medical College, Belgaum, Karnataka, India.

PMID: 25949974 PMCID: PMC4408708 DOI: 10.4103/2249-4863.154661

Abstract

INTRODUCTION: Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. Various risk factors have been found to be associated with drug-induced liver injury (DILI) in general population. The study aimed to determine the prevalence of drug-induced hepatitis and the risk factors associated with the DILI among the patients of pulmonary tuberculosis in Indian patients.

SETTING AND DESIGN: Prospective nested case control study.

MATERIALS AND METHODS: Out of the cohort of 3900 tuberculosis patients who were initiated on anti-tubercular therapy, 150 patients who developed drug-induced liver injury due to short-course chemotherapy under RNTCP were included in the analysis. Thirty cases were being followed up in our hospital and other 120 were referred to us for the management of drug-induced hepatitis from the primary health centers. The diagnostic criteria's for DILI were made according to the American Thoracic Society criteria. Analyses of various risk factors were done for the development of DILI.

RESULTS: The prevalence of DILI in the present study was 3.8%. It was observed that DILI patients were older and their serum albumin levels were lower, and they had multiple co-morbid conditions. Regular alcohol intake, more extensive disease associated with radiological and female gender were observed to be independent risk factors for the development of DILI.

CONCLUSIONS: Of the various risk factors analyzed, advanced age, hypoalbuminemia, regular alcohol intake and advanced nature of the disease were independent risk factors for the development of DILI. The risk of development of hepatitis is increased in the presence of one or more of these risk factors.

Keywords: Adverse drug reaction; chemotherapy; drug-induced hepatitis; drug-induced liver injury; hepatic failure; tuberculosis

References

  1. Am Rev Respir Dis. 1991 Jun;143(6):1350-2 - PubMed
  2. Am J Respir Crit Care Med. 2008 Jun 15;177(12 ):1391-6 - PubMed
  3. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):707-12 - PubMed
  4. Thorax. 1996 Feb;51(2):132-6 - PubMed
  5. Bull Int Union Tuberc. 1976;51(1):203-8 - PubMed
  6. Trop Gastroenterol. 2011 Jul-Sep;32(3):167-74 - PubMed
  7. Curr Opin Infect Dis. 2005 Apr;18(2):133-40 - PubMed
  8. Intern Med. 2013;52(19):2209-14 - PubMed
  9. Eur Respir J. 1995 Aug;8(8):1384-8 - PubMed
  10. Dev Pharmacol Ther. 1990;15(3-4):159-65 - PubMed
  11. PLoS One. 2013 May 16;8(5):e64622 - PubMed
  12. Tuberk Toraks. 2012;60(2):136-44 - PubMed
  13. Tubercle. 1981 Jun;62(2):95-102 - PubMed
  14. Am J Respir Crit Care Med. 2002 Oct 1;166(7):916-9 - PubMed
  15. Am Rev Respir Dis. 1984 Jan;129(1):58-61 - PubMed
  16. Am Rev Respir Dis. 1986 Jun;133(6):963-5 - PubMed
  17. Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52 - PubMed
  18. Int J Tuberc Lung Dis. 2005 May;9(5):534-40 - PubMed
  19. Int J Tuberc Lung Dis. 2001 Jan;5(1):65-9 - PubMed
  20. Int J Infect Dis. 2014 Nov;28:95-100 - PubMed
  21. Tubercle. 1986 Jun;67(2):99-108 - PubMed
  22. Am Rev Respir Dis. 1978 Sep;118(3):461-6 - PubMed
  23. Chest. 1991 Feb;99(2):465-71 - PubMed
  24. Int J Tuberc Lung Dis. 2002 Aug;6(8):699-705 - PubMed

Publication Types